Donor-derived infection post-transplant. Case of disseminated Strongyloides in kidney recipient presenting w/dyspnea and periumbilical purpura few months post-transplant.Diagnosis made by microscopy of BAL.Routine screening of donors by Ab testing is key.Treatment with ivermectin
With so many people waiting for a kidney news like this brings hope! Thoughtful ethical examination clearly needed but overall this feels like an exciting advance. https://t.co/2D1s7ACXeS
Delighted to share our state-of-the-art review on treatment of IgAN https://t.co/BWryLAFXDA in @NDTsocial. Honoured to work on this with @IgAN_JBarratt and @MichelleOShaug3. Exciting times for IgAN therapeutics!
Our new paper "Improving access to kidney care for people with severe mental health difficulties" https://t.co/Q6q0FpR9Ib
Findings show the need for integrated physical and mental healthcare, and a “whole person” approach to addressing the interaction bw #CKD and #mentalhealth
INS Winter Meeting
📅 Saturday 28th of January.
🏫 Albert Hall, The Royal College of Surgeons in Ireland, Dublin.
🎓 Packed programme. 6 CPD points.
👉 Register: https://t.co/5zF3FeywEm
#IrishNeph
Can COVID-19 vaccines trigger a flare of GN?
Our study in @JASN_News is the 1st to study this question at a population level using data from >1000 patients in British Columbia, Canada
https://t.co/utpJEjfN3w
@UBCNephrology@SeanJBarbour@BCRenal@OttawaRenal
Thread
1/
Endocarditis assoc GN is distinct from ‘classic’ infection assoc GN. ANCA +’ve in 28%, necrotising and crescentic GN in 53%. Immunosuppression has a role! #KidneyWk
State of the Art lecture: Melissa A Moore: (2) these barriers overcome by developing a ‘PseudoU’ modified nucleoside, and using lipid nanoparticle transport complex. #KidneyWk
State of the Art lecture - Melissa A Moore: Biologics act extracellularly, but 90% of proteins are intracellular or transmembrane. mRNA on the other hand ‘enables the body to produce its own medicines’. The tricky bits are delivery, and not triggering innate immunity. #KidneyWk
Homer W.Smith award winner Jeff Sands: AMPK is like the spare tyre in your car, ready for use if the V2R pathway through PKC isn’t working. AMPK activators (like metformin) can help treat NDI, upregulating UT-A1 + AQ-2 #KidneyWk
In LN - Get steroids down early. Always check adherence. Tac an attractive option for LN in pregnancy. CNI’s if heavily proteinuric, belimumab for longer term. @kidneydoc101#KidneyWk
EMPA-KIDNEY: 6000 pts, 28% reduction in primary composite outcome, 29% reduction in kidney disease progression and 27% reduction in ESKD or CV death, with or without diabetes.Maintained in eGFR’s <30, with larger impacts in those with higher albuminuria. Serious kudos. #KidneyWk
Cemdisiran phase 2 trial in IgAN, (silencing C5 mRNA in liver): 31 pts (9 placebo) all had >1gm/ proteinuria, normal eGFRs and on RAASi at baseline. At 32 weeks, 37% reduction in proteinuria, haematuria and a trend of slower reduction in eGFR. #KidneyWk
VALOR-CKD results: Veverimer for metabolic acidosis. Negative study, but placebo group bicarbonate levels were c. 21meq/L and didn’t really drop. #KidneyWk
Measured optimism from @XPOTASN on the future of the WAK. LED driven photo-oxidation of titanium dioxide helps to oxidise urea and other uraemic toxins to harmless gases, potentially solving the dialysate volume issue - an idea inspired by self-cleaning glass windows! #kidneyWk